Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary M Horowitz

Showing results (191-200 of 260) with videos related to

Pageof 26
Sort By:
Blood|August 2, 2003
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphomaKoen van Besien, Fausto R Loberiza, Ruta Bajorunaite, et al.
Transplantation and Cellular Therapy|March 29, 2021
Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes-Long-Term Follow-Up of the BMT CTN 0901 Clinical TrialBart L Scott, Marcelo C Pasquini, Mingwei Fei, et al.
BMC Cancer|April 4, 2018
Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemiaEhab Atallah, Charles A Schiffer, Kevin P Weinfurt, et al.
Blood Advances|March 21, 2019
Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cellsYi-Bin Chen, Jennifer Le-Rademacher, Ruta Brazauskas, et al.
Blood|October 18, 2014
HLA-C expression levels define permissible mismatches in hematopoietic cell transplantationEffie W Petersdorf, Theodore A Gooley, Mari Malkki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2021
Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic MalignanciesLeo Luznik, Marcelo C Pasquini, Brent Logan, et al.
Blood|March 25, 2004
A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcomeCorey S Cutler, Stephanie J Lee, Peter Greenberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2017
Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic LeukemiaPartow Kebriaei, Claudio Anasetti, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 26, 2018
Cohort-Controlled Comparison of Umbilical Cord Blood Transplantation Using Carlecortemcel-L, a Single Progenitor-Enriched Cord Blood, to Double Cord Blood Unit TransplantationPatrick J Stiff, Pau Montesinos, Tony Peled, et al.
Blood|October 20, 2011
Risk factors for acute GVHD and survival after hematopoietic cell transplantationMadan Jagasia, Mukta Arora, Mary E D Flowers, et al.
Pageof 26

Showing results (191-200 of 260) with videos related to

Sort By:
Pageof 26
Blood|August 2, 2003
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphomaKoen van Besien, Fausto R Loberiza, Ruta Bajorunaite, et al.
Transplantation and Cellular Therapy|March 29, 2021
Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes-Long-Term Follow-Up of the BMT CTN 0901 Clinical TrialBart L Scott, Marcelo C Pasquini, Mingwei Fei, et al.
BMC Cancer|April 4, 2018
Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemiaEhab Atallah, Charles A Schiffer, Kevin P Weinfurt, et al.
Blood Advances|March 21, 2019
Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cellsYi-Bin Chen, Jennifer Le-Rademacher, Ruta Brazauskas, et al.
Blood|October 18, 2014
HLA-C expression levels define permissible mismatches in hematopoietic cell transplantationEffie W Petersdorf, Theodore A Gooley, Mari Malkki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2021
Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic MalignanciesLeo Luznik, Marcelo C Pasquini, Brent Logan, et al.
Blood|March 25, 2004
A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcomeCorey S Cutler, Stephanie J Lee, Peter Greenberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2017
Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic LeukemiaPartow Kebriaei, Claudio Anasetti, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 26, 2018
Cohort-Controlled Comparison of Umbilical Cord Blood Transplantation Using Carlecortemcel-L, a Single Progenitor-Enriched Cord Blood, to Double Cord Blood Unit TransplantationPatrick J Stiff, Pau Montesinos, Tony Peled, et al.
Blood|October 20, 2011
Risk factors for acute GVHD and survival after hematopoietic cell transplantationMadan Jagasia, Mukta Arora, Mary E D Flowers, et al.
Pageof 26